Free nationwide delivery on orders over $129

BioPractica BioGaia Gastrus Chewable (Mandarin) 60t

BioPractica

BioPractica BioGaia Gastrus Chewable (Mandarin) 60t

$91.60

Member Only Product

BioPractica is available to members.

Already a member? Log in to see your scripts

shipping icon Free delivery Australia-wide on orders over $129.

BioGaia® Gastrus contains Limosilactobacillus reuteri DSM 17938 + Limosilactobacillus reuteri ATCC PTA 6475, sourced from human origin.

Targeted support with this unique Limosilactobacillus reuteri strain combination.


  • Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
  • Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs)
  • Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer
  • Delivers a daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose
  • Does not require refrigeration, for ease of use and convenience.


Adults: Consume 1 chewable tablet daily, with meals, or as directed by your healthcare professional.

Store below 25°C in a cool, dry place.

No refrigeration required.

Each BioGaia® Gastrus chewable tablet contains:

Lactobacillus reuteri (DSM 17938) 350 mg (100 million organisms)
Lactobacillus reuteri (ATCC PTA 6475) 350 mg (100 million organisms)


Use only as directed and if symptoms persist consult your health professional. For practitioner dispensing only.

BioGaia® Gastrus contains Limosilactobacillus reuteri DSM 17938 + Limosilactobacillus reuteri ATCC PTA 6475, sourced from human origin.

Targeted support with this unique Limosilactobacillus reuteri strain combination.


  • Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
  • Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs)
  • Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer
  • Delivers a daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose
  • Does not require refrigeration, for ease of use and convenience.


Adults: Consume 1 chewable tablet daily, with meals, or as directed by your healthcare professional.

Store below 25°C in a cool, dry place.

No refrigeration required.

Each BioGaia® Gastrus chewable tablet contains:

Lactobacillus reuteri (DSM 17938) 350 mg (100 million organisms)
Lactobacillus reuteri (ATCC PTA 6475) 350 mg (100 million organisms)


Use only as directed and if symptoms persist consult your health professional. For practitioner dispensing only.

Reviews